Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
The cannabinoid class of medications are widely used to treat disease or alleviate symptoms such as spasticity and pain associated with MS. However, the exact molecular mechanisms by which they exert their beneficial effects remain unknown. Recent research and clinical trials demonstrated that cannabinoids may not only alleviate the symptoms of MS, but may also slow the disease progression and delay the onset of symptoms. As such, investigative research is now expanding beyond the traditional paradigms of conventional medicine to now include that of the cannabinoids to the forefront of available treatments for MS. In this research, we aim to investigate the role of cannabinoids in improving myelin repair by beneficially altering the cytokine, chemokine, neurotrophin signalling pathway that has previously been shown to govern myelin repair.
Michael Namaka
Ting zhou
CanniMed Therapeutics Inc
Pharmacy / Pharmacology
Pharmaceuticals
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.